Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem Safety and Effectiveness in Thai Patients
NCT00965848Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doripenem in hospital-acquired pneumonia (HAP), Intra-abdominal infection (IAI), complicated urinary tract infection (cUTI), sponsored by Janssen Pharmaceutical. Started Jun 2009; status: completed.
02
Drugs
doripenem
03
Conditions
hospital-acquired pneumonia (HAP)Intra-abdominal infection (IAI)complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT00965848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965848.